Logiscreen

Cryo-Cell International Inc

$3.38
Market Cap 27.23M
ROE 14.2%
Gross Margin 78.4%
Debt/Equity -0.5
Current Ratio 0.7
Revenue QoQ -1.9%
EPS QoQ 0.8%
F-Score 6

About

Cryo-Cell International, Inc. is engaged in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. The company offers advanced cord tissue service, which stores a section of the umbilical cord tissue, which is a source of mesenchymal stem cells that are used in regenerative medicine research targeting potential therapies for a range of conditions, including heart disease, stroke, multiple sclerosis, and diabetes; and reproductive tissue storage service for cryopreserved embryos, oocytes, and sperm that offers reproductive tissue services, including short and longer-term cryogenic storage, inter-facility transportation coordination, and special quarantined cryogenic storage for infectious disease positive specimens. It stores approximately 300,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.

Exchange
AMEX
Sector
Healthcare
Industry
Medical Care Facilities

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-10.34
vs median 36.93
P/B
-1.50
vs median 2.32
ROE
0.16
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics